Related Experiment Videos
Jaks and stats as therapeutic targets
J J O'Shea1, R Visconti, T P Cheng
1National Institutes of Health, Bethesda, MD 20892-1820, USA. osheajo@mail.nih.gov
Annals of the Rheumatic Diseases
|October 29, 2000
Summary
This review explores how cytokines, Janus kinases (Jaks), and Stat proteins regulate immune responses. It discusses targeting these molecules for novel immunosuppressive therapies.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Cytokines are key regulators of immune responses.
- Many cytokines signal through Type I and Type II cytokine receptor families.
- These receptors activate Janus kinases (Jaks) and Signal Transducer and Activator of Transcription (Stat) proteins.
Purpose of the Study:
- To review the critical functions of cytokines, cytokine receptors, Jaks, and Stats in immune regulation.
- To highlight the importance of Jaks and Stats through examples of human and mouse mutations.
- To consider the potential for targeting these molecules in the development of novel immunosuppressive compounds.
Main Methods:
- Literature review of studies on cytokines, cytokine receptors, Jaks, and Stats.
- Analysis of data from human and mouse mutation studies.
- Exploration of therapeutic targeting strategies.
Main Results:
- Cytokines play essential roles in immune system function.
- Type I and Type II cytokine receptors are crucial signaling intermediaries.
- Jaks and Stats are vital for cytokine-mediated immune responses, as evidenced by mutation studies.
Conclusions:
- The JAK-STAT pathway is fundamental to cytokine signaling and immune regulation.
- Understanding these pathways provides opportunities for therapeutic intervention.
- Targeting cytokine signaling molecules offers a promising avenue for developing new immunosuppressive drugs.